Apr 26, 2012 | Domain-B
Alpharma divests API business to 3i for $395 million
Specialty pharmaceutical multinational Alpharma Inc today announced the sale of its active pharmaceutical ingredients business to private equity and venture capital group 3i for $395 million.
Apr 26, 2012 | Domain-B
Alpharma rejects King Pharmaceuticals' $1.55 billion offer as inadequate
New Jersey-based specialty pharmaceuticals company Alpharma Inc.'s board of directors took a leaf out of biotechnology firm ImClone Systems and formally rejected King Pharmaceuticals' hostile takeover bid of $37.00 a share on Friday, asserting that the offer was too low.
Apr 26, 2012 | Domain-B
King Pharma to acquire Alpharma for around $1.6 billion
Contract manufacturer and seller of branded prescription products King Pharmaceuticals Inc and Alpharma Inc have announced the inking of a definitive merger agreement.
"Alstom SA (ALO) - Nuclear Energy - Deals and Alliances Profile" now...
It designs, and supplies a complete range of technologically advanced products and systems.